Ways to use the ACR’s advocacy toolkit to contact Congressional representatives and articulate your message to lawmakers
American College of Rheumatology Advances Pediatric Rheumatology through Residents Program
The ACR’s Pediatric Rheumatology Residents Program is designed to motivate trainees to pursue the subspecialty
ACR Musculoskeletal Ultrasound Course Helps Rheumatologists, Health Professionals Expand Their Skills
This intermediate-level course combines lectures and practical hands-on experience in the application of musculoskeletal ultrasound for rheumatology
Award Recipient Advances Rheumatology Education with e-Learning Tools
With a grant from the ACR’s Rheumatology Research Foundation, Christopher Collins, MD, is supplying e-learning tools for use in rheumatology education
Practice Page: Deadline Approaching to Implement ICD-10 Coding Changes
Unless Congress enacts a delay, healthcare providers will need to implement the new ICD-10 code set changes by October 1, 2014, a mere 18 months away
Prednisone Might be the Missing Ingredient in the American College of Rheumatology’s Recommendations for Treating Patients with Rheumatoid Arthritis
A combination therapy with glucocorticoids may be the gold standard for treating patients with rheumatoid arthritis (RA)
Blue Ribbon Panel on Academic Rheumatology Publishes Final Report
Report offers recommendations to address critical issues with training, practice, and research
The ACR’s Simple Tasks Campaign Expands its Reach, Launches a Blog, and Earns its Fourth Award
Simple Tasks exhibited at the annual meetings of two physician groups, and recently hand-delivered ACR materials to lawmakers on Capitol Hill
ACR Adopts Strategic Plan to Advance Rheumatology
Recommendations in the areas of healthcare economics, rheumatology practice, and research are included in the ACR’s strategic plan for 2013 – 2016
ACR Advances Legislation to Increase Patients’ Access to Biologic Drugs to Treat Rheumatoid Arthritis and Other Conditions
The Patients’ Access to Treatments Act of 2013 would prevent insurance companies from tacking on an additional cost-sharing fee for the specialty medications
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 54
- Next Page »